Tyramine infusions in bipolar illness: behavioral effects and longitudinal changes in pressor sensitivity
- 1 November 1979
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 136 (11) , 1460-1463
- https://doi.org/10.1176/ajp.136.11.1460
Abstract
Steady state intravenous tyramine dose pressor-response tests were administered to a patient with bipolar illness during depressed and hypomanic phases of her illness. The greatest tyramine sensitivity while unmedicated occurred when the patient was hypomanic, and the least sensitivity when she was depressed before her first switch. The data raise the possibility that changes in peripheral alpha-adrenergic receptor sensitivity accompany spontaneous mood cycles. Tyramine produced a replicable mood and cognitive alteration only in the infusion closest to the switch from hypomania to depression, suggesting that the CNS may be particularly susceptible to peripheral noradrenergic inputs at specific points in bipolar illness.This publication has 10 references indexed in Scilit:
- Comparative behavioral effects of clorgyline and pargyline in man: A preliminary evaluationPsychopharmacology, 1979
- Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholaminesNeuropharmacology, 1978
- Peripheral ?-adrenoreceptor and central dopamine receptor activity in depressive patientsPsychopharmacology, 1978
- Does receptor supersensitivity accompany depressive illness?American Journal of Psychiatry, 1978
- The menstrual cycle and the tyramine pressor response test.British Journal of Clinical Pharmacology, 1977
- PLATELET AND PLASMA AMINE OXIDASE INHIBITION AND URINARY AMINE EXCRETION CHANGES DURING PHENELZINE TREATMENTJournal of Nervous & Mental Disease, 1977
- INTRAVENOUS TYRAMINE PRESSOR RESPONSE IN DEPRESSIONThe Lancet, 1975
- Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatmentPsychopharmacology, 1975
- Effects of lithium on adrenergic function in manClinical Pharmacology & Therapeutics, 1972
- METABOLISM OF NOREPINEPHRINE-H-3 RELEASED BY TYRAMINE AND RESERPINE1962